Axon Enterprise, Inc $AXON Shares Bought by 1832 Asset Management L.P.

1832 Asset Management L.P. lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 129.2% during the 2nd quarter, HoldingsChannel reports. The firm owned 536,420 shares of the biotechnology company’s stock after purchasing an additional 302,420 shares during the quarter. 1832 Asset Management L.P.’s holdings in Axon Enterprise were worth $444,124,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in AXON. Banque Transatlantique SA purchased a new position in Axon Enterprise during the first quarter worth approximately $31,000. Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise in the 1st quarter worth $33,000. Hemington Wealth Management raised its holdings in shares of Axon Enterprise by 70.8% during the 2nd quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock worth $33,000 after acquiring an additional 17 shares during the period. Whipplewood Advisors LLC raised its holdings in shares of Axon Enterprise by 192.9% during the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after acquiring an additional 27 shares during the period. Finally, NewSquare Capital LLC boosted its position in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after acquiring an additional 25 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on AXON shares. Barclays cut their price objective on shares of Axon Enterprise from $861.00 to $702.00 and set an “overweight” rating for the company in a research report on Thursday, November 6th. Zacks Research downgraded shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Wall Street Zen cut Axon Enterprise from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Finally, Cowen restated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Fifteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $814.00.

Insider Activity

In related news, CFO Brittany Bagley sold 5,000 shares of the stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the transaction, the chief financial officer owned 93,592 shares of the company’s stock, valued at $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total value of $58,520.00. Following the completion of the sale, the chief accounting officer owned 15,003 shares in the company, valued at approximately $11,402,280. This represents a 0.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 38,547 shares of company stock worth $26,385,102. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Stock Up 0.9%

AXON stock opened at $537.75 on Wednesday. The company’s 50 day moving average price is $648.77 and its 200 day moving average price is $724.08. The firm has a market capitalization of $42.43 billion, a price-to-earnings ratio of 170.17, a PEG ratio of 122.46 and a beta of 1.40. Axon Enterprise, Inc has a fifty-two week low of $469.24 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.57, a quick ratio of 2.89 and a current ratio of 3.12.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). Axon Enterprise had a return on equity of 4.29% and a net margin of 10.05%.The firm had revenue of $710.64 million during the quarter, compared to analysts’ expectations of $704.83 million. During the same quarter in the prior year, the firm earned $1.45 EPS. The firm’s revenue was up 30.6% compared to the same quarter last year. On average, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.